Scholarly Index
Marlise R. Luskin
Dana-Farber Cancer Institute; 3,956 total citations; 294 total publications; best world rank #43
Dana-Farber Cancer Institute
3,956Total citations
294Total publications
28H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Acute Lymphoblastic Leukemia research | 2021-2025 | 43 | US 33 | 99.03 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 51 | US 35 | 98.60 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 53 | US 34 | 98.99 |
| Acute Myeloid Leukemia Research | 2021-2025 | 258 | US 146 | 97.72 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 336 | US 151 | 96.45 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 231 | US 123 | 94.67 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 803 | US 331 | 87.81 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 414 | US 165 | 85.40 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 568 | US 206 | 79.68 |
| Chemotherapy-related skin toxicity | 2021-2025 | 661 | US 211 | 42.01 |